MCB295A
Download as PDF
MCB295A - Immunotherapy Colloquium
Course ID
040082
Course Description
Students will explore the current state of the art in immuno-oncology: the therapeutic approach designed to activate a patient's own immune system against cancer. This approach has recently garnered significant excitement as previously incurable cancers are seeing remarkable remissions. The course will provide a brief overview of cancer and the immune system, with a focus on the novel treatments of checkpoint inhibitors, and chimeric antigen receptor transgenic therapies.
Min Units
1
Max Units
1
Repeatable for Credit
No
Grading Basis
SPF - Alternative Grading S, P, F
Career
Undergraduate
Enrollment Requirements
018110
Course Requisites
Molecular & Cellular Biology Major. This is a second-year colloquium course and requires the students to have either completed or to be concurrently enrolled in introductory biology.
May be convened with
Component
Colloquium
Optional Component
No